Journal of the American Academy of Child & Adolescent Psychiatry
Volume 47, Issue 5 , Pages 491-498, May 2008

Pharmacotherapy in the Management of Voiding and Storage Disorders, Including Enuresis and Encopresis

  • WILLIAM G. REINER, M.D.

      Affiliations

    • Corresponding Author InformationCorrespondence to Dr. William G. Reiner, Department of Urology and Department of Psychiatry, University of Oklahoma Health Sciences Center, WP 3150, 920 Stanton L. Young Blvd., Oklahoma City, OK 73104;.
    • ,
  • Christopher J. Kratochvil, M.D. (Assistant Editor)

Dr. Reiner is with the University of Oklahoma Health Sciences Center.

Accepted 17 November 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Psychopharmacology Perspectives aims to discuss practical approaches to everyday issues in pediatric pharmacotherapy. The discussions may address aspects of clinical care related to psychopharmacology for which we do not have adequate applicable controlled trials. Given the need to address symptoms in youths with often complex, severe, and comorbid disorders, recommendations are likely to be off-label from the perspective of the U.S. Food and Drug Administration. We fully appreciate that for virtually all disorders, medication is only one aspect of comprehensive care. This column focuses primarily on psychopharmacological management. Although it is important that clinicians address psychosocial issues in the evaluation and treatment of their patients, such discussion is beyond the specific scope of this feature. These are not meant to be practice guidelines, but rather examples of the thought process that may go into pharmacotherapy decision making.Disclosure: The author reports no conflicts of interest.

PII: S0890-8567(09)62414-X

doi:10.1097/CHI.0b013e31816774c5

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 47, Issue 5 , Pages 491-498, May 2008

Article Tools

* Image Usage & Resolution